WCN26-8197 BUDESONIDE MODULATES B- AND T-CELL IMMUNITY IN PEYER'S PATCHES: IMPLICATIONS FOR IgA NEPHROPATHY

Read full text Summarise with VIRAT
Authors: Roza Ghotbi, Jens Halkjaer Kristensen, Krassimir Mitchev, Johan Häggblad
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

IgA nephropathy (IgAN) is a chronic, immune-mediated kidney disorder characterized by gut-derived renal deposition of galactose-deficient IgA1 antibodies in the glomeruli of the kidney. Peyer’s patches (PPs) in the distal ileum serve as key sites for B-cell priming, IgA class switching, and mucosal immunity. Budesonide, the active substance of nefecon (an FDA-approved targeted-release budesonide formulation), has demonstrated B-cell suppressive effects, yet its tissue-specific immunomodulatory role in PPs remains incompletely defined.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Systemic Lupus Erythematosus Research Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105070–105070
Publication date
25 March 2026
Language
EN